Savvy Update 2/19/24: DiaMyd FDA Fast Track for Immunotherapy, Eversense E3 CGM Gets Expanded Medicare Coverage, Few More FREE Give-a-Way Books, Casting Call for Alerting but Untrained Pets

Savvy Update 2/19/24: DiaMyd FDA Fast Track for Immunotherapy, Eversense E3 CGM Gets Expanded Medicare Coverage, Few More FREE Give-a-Way Books, Casting Call for Alerting but Untrained Pets

Immunotherapy to treat people with type 1 diabetes genotype granted fast track designation by Jill Rollet for Healio.com/endocrinology, 16 February 2024. The FDA granted fast track designation for an immunotherapy to treat type 1 diabetes among people with the human...
Skip to content